X-D Wei - JoVE Visualize

Showing results (41-50 of 56) with videos related to

Pageof 6

Sort By:

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019

[Prognosis of clonal chromosomal abnormalities in Philadelphia negative metaphases cells in chronic myeloid leukemia with tyrosine kinase inhibitor therapy]H F Zhao, Yanli Zhang, J Y Hu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022

[Efficacy and safety analysis of eltrombopag and recombinant human thrombopoietin combined with immunosuppressive therapy for severe aplastic anemia]F F Yuan, Q L Zhang, L N Zhang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 4, 2024

[A single-center retrospective study of salvage allogeneic hematopoietic stem cell transplantation pretreated with MeCBA regimen for refractory/relapsed acute myeloid leukemia]F F Yuan, Y Q Wang, M H Li, et al.

Zhonghua Nei Ke Za Zhi|November 1, 2019

[The efficacy and safety of co-transplantation of unrelated donor peripheral blood stem cells combined with umbilical mesenchymal stem cells in patients with refractory severe aplastic anemia-Ⅱ]M Y Zhao, Y W Fu, Q Wang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 5, 2019

[Therapeutic effect of combined use of interferon alpha-1b, interleukin-2 and thalidomide on reversing minimal residual disease in acute myeloid leukemia]R H Mi, L Chen, X D Wei, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019

[Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia]Y Liu, R H Mi, L Chen, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 30, 2018

[The expression of CRLF2 in adult Ph negative acute B lymphocytic leukemia and its prognostic significance]H Chen, X J Wang, S Liu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 13, 2021

[Venetoclax with low-dose cytarabine for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: results from the Chinese cohort of a phase three randomized placebo-controlled trial]Y Hu, J Jin, Y Zhang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016

[Outcome analysis of allogeneic hematopoietic stem cell transplantation for 41 patients with severe aplastic anemia]J Zhou, Yanli Zhang, Y W Fu, et al.

Zhonghua Nei Ke Za Zhi|December 6, 2016

[A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia]J Zhou, Y W Fu, L J Liang, et al.

Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:

Pageof 6

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019

[Prognosis of clonal chromosomal abnormalities in Philadelphia negative metaphases cells in chronic myeloid leukemia with tyrosine kinase inhibitor therapy]H F Zhao, Yanli Zhang, J Y Hu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022

[Efficacy and safety analysis of eltrombopag and recombinant human thrombopoietin combined with immunosuppressive therapy for severe aplastic anemia]F F Yuan, Q L Zhang, L N Zhang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 4, 2024

[A single-center retrospective study of salvage allogeneic hematopoietic stem cell transplantation pretreated with MeCBA regimen for refractory/relapsed acute myeloid leukemia]F F Yuan, Y Q Wang, M H Li, et al.

Zhonghua Nei Ke Za Zhi|November 1, 2019

[The efficacy and safety of co-transplantation of unrelated donor peripheral blood stem cells combined with umbilical mesenchymal stem cells in patients with refractory severe aplastic anemia-Ⅱ]M Y Zhao, Y W Fu, Q Wang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 5, 2019

[Therapeutic effect of combined use of interferon alpha-1b, interleukin-2 and thalidomide on reversing minimal residual disease in acute myeloid leukemia]R H Mi, L Chen, X D Wei, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019

[Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia]Y Liu, R H Mi, L Chen, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 30, 2018

[The expression of CRLF2 in adult Ph negative acute B lymphocytic leukemia and its prognostic significance]H Chen, X J Wang, S Liu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 13, 2021

[Venetoclax with low-dose cytarabine for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: results from the Chinese cohort of a phase three randomized placebo-controlled trial]Y Hu, J Jin, Y Zhang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016

[Outcome analysis of allogeneic hematopoietic stem cell transplantation for 41 patients with severe aplastic anemia]J Zhou, Yanli Zhang, Y W Fu, et al.

Zhonghua Nei Ke Za Zhi|December 6, 2016

[A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia]J Zhou, Y W Fu, L J Liang, et al.

Pageof 6